https://www.has-sante.fr/jcms/p_3224940/fr/hepcludex 2020 false false false France French evaluation of the transparency committee treatment outcome insurance, health, reimbursement Bulevirtide antiviral agents hepatitis D, chronic drug therapy, combination bulevirtide adult guidelines for drug use injections, subcutaneous
--- https://www.ema.europa.eu/en/medicines/human/EPAR/hepcludex 2020 false false false United Kingdom French English treatment outcome syndication feed summary of product characteristics package leaflet drug evaluation drug approval europe antiviral agents antiviral agents orphan drug production adult hepatitis D, chronic injections, subcutaneous product surveillance, postmarketing drug interactions pregnancy breast feeding bulevirtide drug evaluation, preclinical Bulevirtide Bulevirtide